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Abstract 
Background: Oxycodone is an opioid that is prescribed to treat multiple types of pain, especially when other opioids 
are ineffective. Unfortunately, similar to other opioids, repetitive oxycodone administration has the potential to lead 
to development of analgesic tolerance, withdrawal, and addiction. Studies demonstrate that chronic opioid exposure, 
including oxycodone, alters gene expression profiles and that these changes contribute to opioid-induced analgesic 
effect, tolerance and dependence. However, very little is known about opioids altering the translational machinery of 
the central nervous system. Considering that opioids induce clinically significant levels of hypoxia, increase intracel-
lular Ca2+ levels, and induce the production of nitric oxide and extracellular glutamate transmission, we hypothesize 
that opioids also trigger a defensive mechanism called the integrated stress response (ISR). The key event in the ISR 
activation, regardless of the trigger, is phosphorylation of translation initiation factor 2 alpha (eIF2α), which modulates 
expression and translational activation of specific mRNAs important for adaptation to stress. To test this hypothesis, 
we used an animal model in which female rats were orally gavaged with 15 mg/kg of oxycodone every 24 h for 
30 days.
Results: We demonstrated increased levels of hsp70 and BiP expression as well as phosphorylation of eIF2α in vari-
ous rat brain areas after oxycodone administration. Polysomal analysis indicated oxycodone-induced translational 
stimulation of ATF4 and PDGFRα mRNAs, which have previously been shown to depend on the eIF2α kinase activa-
tion. Moreover, using breast adenocarcinoma MCF7 cells, which are known to express the μ-opioid receptor, we 
observed induction of the ISR pathway after one 24-h treatment with oxycodone.
Conclusions: The combined in vivo and in vitro data suggest that prolonged opioid treatment induces the inte-
grated stress response in the central nervous system; it modulates translational machinery in favor of specific mRNA 
and this may contribute to the drug-induced changes in neuronal plasticity.
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Background
Oxycodone (6-deoxy-7,8-dehydro-14-hydroxy-3-O-
methyl-6-oxomorphine) is a strong semi-synthetic 
opioid. It is prescribed to treat multiple types of pain, 
especially when other opioids are ineffective. Oxyco-
done has close structural similarity to morphine and 
heroin and binds not only μ- but also κ-opioid receptors. 
Oxycodone’s ability to rapidly cross the blood–brain bar-
rier allows it to reach higher concentrations in the cen-
tral nervous system (CNS) than in plasma (reviewed in 
[1]). These properties contribute to oxycodone’s power-
ful analgesic as well as potential for abuse and addiction. 
The use of oxycodone in the US increased by 866 % from 
1997 to 2007 and accounted for almost half of total opi-
oids dispensed in 2008 [2, 3]. In 2012, the US population 
consumed over 77 tons of oxycodone [4]. Unfortunately, 
like other opioids, repetitive oxycodone administra-
tion has the potential to lead to development of analge-
sic tolerance, withdrawal, and addiction. Several studies 
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demonstrate that chronic opioid exposure, including oxy-
codone, alters gene expression profiles. These changes in 
gene expression contribute to the opioid-induced anal-
gesic effect, as well as the development of tolerance, and 
dependence [5–12]. However, little is known about opi-
oids ability to alter the translational machinery in CNS 
tissues.
Opioids are known to induce clinically significant lev-
els of hypoxia due to respiratory depression, increase 
intracellular Ca2+ levels (reviewed in [13]), and induce 
the production of nitric oxide (NO) [14], and extracel-
lular glutamate transmission [15]. Moreover, opioid 
exposure is linked to the induction of oxidative stress in 
neuronal and non-neuronal tissues, and in cell cultures 
[16–22] (rev. in [23]). Hypoxia, excessive production of 
reactive oxygen species (ROS) and NO, increased extra-
cellular glutamate, and induction of endoplasmic reticu-
lum stress by aberrant calcium flow, have all been shown 
to trigger a defensive mechanism called the integrated 
stress response (ISR) [24]. The key event in ISR, regard-
less of the trigger, is phosphorylation of translation ini-
tiation factor 2 alpha (eIF2α) that modulates expression 
and translational activation of specific mRNAs impor-
tant for adaptation to the stress. In metazoa, there are 
four kinases that phosphorylate eIF2α: (1) GCN2, general 
control nonderepressible 2 kinase, which is activated in 
response to amino acid deprivation, UV irradiation, and 
proteasome inhibition; (2) HRI, the hemin-regulated 
inhibitor kinase, that was found to inhibit protein synthe-
sis in heme-deprived lysates and stressed cells; (3) PKR, 
protein kinase R, which is activated by double-stranded 
RNA and shuts down translation during viral infection; 
and (4) PERK, a PKR-like endoplasmic reticulum (ER) 
kinase, which is activated as part of the unfolded pro-
tein response (UPR) to the ER stress [25]. Phosphoryla-
tion of eIF2α reduces general translation but allows the 
ribosome to initiate translation of specific mRNAs con-
taining upstream open-reading frames (uORF) in their 
5′UTR via leaky scanning [26], including the transcrip-
tion factor ATF4 (a cAMP element binding transcrip-
tion factor) [27, 28]. The expression level of ATF4 and 
downstream events then determine whether the cell will 
adapt to the stress condition and continue to grow or will 
undergo apoptosis. The induction of the ISR in brain tis-
sues due to chronic opioid administration has never been 
investigated.
We hypothesize that chronic opioid administration 
triggers the ISR and thus modulates phospho-eIF2α-
dependent translation. To test this hypothesis, we used 
an animal model in which female rats were orally gav-
aged with 15  mg/kg oxycodone every 24  h for 30  days. 
In this study we observed that chronic oxycodone expo-
sure induces oxidative/nitrosidative stresses in three 
areas of the brain: the nucleus accumbens, cortex, and 
brain stem. Western blotting and immunohistochemi-
cal analyses demonstrates that activation of the ISR in 
oxycodone-exposed brain tissues occurs, inducing over-
expression of hsp70 and BiP, increasing phosphorylation 
of eIF2α and translationally up-regulating the phospho-
eIF2α-dependent mRNAs. To investigate whether oxyco-
done induces ISR in the receptor-dependent manner we 
treated breast adenocarcinoma MCF7 cells, which are 
known to express the μ-opioid receptor, with oxycodone 
for 24 h and demonstrated that activation of the ISR was 
partially abrogated by pre-treatment of cells with the opi-
oid receptor antagonist naloxone.
Results
Daily oxycodone treatment activates signaling pathways 
characteristic of both acute and chronic opioid response 
in rat nucleus accumbens
First, to determine the antinoceptive effect of oxycodone 
and development of tolerance in rats, we performed a 
hot plate assay. Rats were placed on a hot plate and the 
latency lick the hind paw was measured (Fig.  1a). The 
latency time for the lower dose, 7.5 mg/kg, of oxycodone-
treated rats was nearly double that of untreated rats, 
while at high dose, 15 mg/kg, the latencies of oxycodone-
treated rats increased threefold from 8.1  s to approxi-
mately 24  s. The high doze treatment with oxycodone, 
15  mg/kg, for 30  days showed development of effective 
chronic analgesia, similar to that seen in human dosing. 
Thus, to study the effect of chronic oxycodone exposure, 
we treated rats with either vehicle (water) or 15  mg/kg 
oxycodone by oral gavage every 24 h for 30 days.
Because of the potential for the development of abuse 
and addiction, we investigated the effect of oxycodone 
on reward signaling in nucleus accumbens of animals 
sacrificed 2  h after administration of the last dose. It 
has been found that PKC and CaMKII are responsible 
for activation of the mitogen activated protein kinase 
Erk1/2 in nucleus accumbens after acute opioid expo-
sure, while PKA activates Erk1/2 during chronic treat-
ment (reviewed in [13]). Activation of Erk1/2 leads to 
increased expression of immediate-early genes, includ-
ing c-fos, which is known to account for the opioid 
rewarding effect ([29]; reviewed in [30]). To investigate 
whether our regiment of treatment induces chronic 
response, we monitored the level of phosphorylation 
of CaMKII, PKA, and Erk1/2, as well as the expres-
sion level of cFos in nucleus accumbens by western 
blot analysis. Each sample lysate contained the nucleus 
accumbens tissue from three rats. The oxycodone data 
(O) were normalized to the corresponding water-con-
trol data (W) from the same treatment experiment. 
Results are presented on Fig.  1b as the mean of three 
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independent treatment (drug administration) experi-
ments (±SEM). Student’s t test was applied to the data 
to determine statistical significance. Western blot anal-
ysis shows an increase from 1.5- to over 3-fold in the 
phosphorylation level of CaMKII, PKA, and Erk1/2 
kinases in nucleus accumbens lysates of rats treated 
with oxycodone compared to that of water-treated ani-
mals (Fig. 1b). In agreement with Erk1/2 activation, the 
cFos protein expression increased more than 1.5-fold 
in the nucleus accumbens of oxycodone-exposed rats 
(Fig. 1b). These data indicate that the proposed dosing 
of oxycodone and daily regimen for 30  day produces 
neuronal activation in the nucleus accumbens that cor-
relates with both acute and chronic signalling leading to 
rewarding properties.
Chronic oxycodone treatment induces oxidative 
and nitrosidative stresses
To investigate whether chronic oxycodone induces oxi-
dative stress in rat brain, we monitored the level of the 
8-Hydroxyguanosine (8H) signal as a marker of oxidative 
damage in nucleic acids. Immunohistochemical analy-
sis showed a significant increase in staining of 8-H in 
the nucleus accumbens, cortex, and brain stem areas in 
oxycodone-exposed rats (Fig. 2a). Increased 8-H staining 
was observed in the nucleus of various cell types, includ-
ing neuronal and glial cells, suggesting the induction of 
oxidative damage to DNA is a systemic effect of chronic 
oxycodone exposure.
Opioid use is also linked to excessive production of 
NO [16]. Increased levels of NO and superoxide form 
peroxynitrite, which modifies tyrosine, produces 3-nitro-
tyrosine (3N) and leads to protein damage. To inves-
tigate whether chronic oxycodone treatment induces 
protein modification caused by oxidative and nitrosida-
tive stresses we monitored the level of 3-nitrotyrosine 
in rat brain lysates. Each lysate sample contained corre-
sponding tissues from three rats. The 3N signal was nor-
malized to the corresponding actin signal in each sample 
and then oxycodone data was normalized to the corre-
sponding water data (Fig. 2b). The graph represents the 
mean ratio of oxycodone to water data obtained in three 
separate experiments using lysates from different drug 
administration experiments (±SEM). Data was analyzed 
by Student’s t test. Dot-blot analysis shows a significant 
increase in 3N-Ab immunoreactivity in all three brain 
lysates: nucleus accumbens, cortex, and brain stem, from 
oxycodone-exposed animals (Fig.  2b). These data indi-
cate that, like other opioids, prolonged oxycodone treat-
ment induces oxidative and nitrosidative stress in rat 
brain.
water 
Oxy 7.5  
mg/kg 


















































Fig. 1 Model for chronic exposure to oxycodone dosing. a Hot plate 
assay to test the antinociceptive effect of oxycodone and the time of 
tolerance development in rats. Oxycodone (7.5 or 15 mg/kg) or water 
was administered by oral gavage every 24 h for 29 days. Rats were 
placed on a hot plate and the time spent until they licked the hind 
paw was measured. Each point represents a mean value of measure-
ment from 8 animals (±SEM). There was an effect of treatment (F2, 
21 = 26.08, p < 0.0001), day (F7, 147 = 14.03, p < 0.0001) and a treat-
ment × day interaction (F14, 147 = 5.38, p < 0.0001). *p < 0.05 vs water; 
# p < 0.05 vs oxy 7.5 mg/kg (Fisher’s PLSD). Oxy oxycodone; water 
vehicle treatment. b Western blot analyses of signalling pathways of 
rewarding circuit in nucleus accumbens. Representative images of 
western blots of total and phosphorylated CaMKII, total and phos-
phorylated PKA, total and phosphorylated Erk1/2, cFos, and GAPDH 
in nucleus accumbens of water (W) and oxycodone (O) treated rats. 
Below panel—graphs representing the densitometric analysis of 
western blots. The graphs represent the mean ratio of phosphoryl-
ated protein to corresponding total protein, and mean ratio of cFos to 
GAPDH. Oxycodone data were normalized to that in water samples 
from three different drug administration experiments (±SEM). Data 
was analyzed by Student’s t test. P-CaMKII/CaMKII, p < 0.001; P-PKA/
PKA, p < 0.05; P-Erk1/2/Erk1/2, p < 0.05; cFos/GAPGH, p < 0.05. Open 
bars water samples; gray filled bars oxycodone samples
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Oxycodone induces the integrative stress response in rat 
brain
To investigate whether oxycodone induces the ISR we 
monitored the expression levels of hsp70 in brain lysates. 
Hsp70 is one of the major heat shock proteins induced in 
the central nervous system as part of the general response 
to a variety of cellular stresses (reviewed in [31]). Real-
time PCR analysis of total RNA isolated from nucleus 
accumbens, cortex and brain stem lysates showed a 7- to 
17-fold increase in hsp70 mRNA level in all three tis-
sues from the oxycodone-exposed animals compared to 
that from the water-treated animals (data not shown). 
In agreement with real-time PCR data, western blot 
analysis of lysates from the nucleus accumbens, cor-
tex and brain stem showed an increase in hsp70 protein 
levels in all three brain areas of oxycodone-treated rats 
(Fig.  3a, upper panels). Overexpression of hsp70 in the 
nucleus accumbens, cortex and brain stem lysates sug-
gests that chronic oxycodone administration induces cel-
lular stress in the rat brain. We also observed increased 
levels of hsp70 in blood samples of oxycodone-exposed 
animals suggesting a systemic effect of oxycodone (data 
not shown).
To investigate whether oxycodone induces the 
unfolded protein response, which is one of the pathways 
that triggers the ISR, we monitored the expression levels 
of BiP. Chaperone BiP serves as a sensor of endoplas-
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Fig. 2 Chronic oxycodone treatment induces biomarkers of oxida-
tive and nitrosidative stresses. a. Immunohistochemical analysis of 
oxidized DNA in nucleus accumbens (NuAcc), cortex, and brain stem 
of rats treated with water (W) or oxycodone (O). Tissues were stained 
with antibodies against 8-Hydroxyguanosine (8H). Representative 
images of area next to anterior commissure (ac) in NuAcc, striatum in 
cortex area, cerebellum in brain stem area. Scale bar denotes: NuAcc, 
100 μm; Cortex, 50 μm; Stem, 20 μm. Below the images is statistical 
analysis of the data. Open bars water samples; gray filled bars oxyco-
done samples. The intensity of 8H-Ab stating in nucleus accumbens, 
cortex, and cerebellum was analyzed using MeanQ method. The 
graphs represent the mean value of signal in three different animals 
(±SEM). Data was analyzed by Student’s t test. NuAcc, n = 9 fields in 
water and n = 6 fields in oxycodone samples containing 9–19 cells 
each, p < 0.001. Cortex, n = 9 fields in water and n = 5 fields in oxy-
codone samples containing 6–18 cells each, p < 0.001. Stem, n = 5 
fields in water and n = 5 fields in oxycodone cerebellums contain-
ing 23–51 cells each, p < 0.001. b Dot-blot analysis of lysates from 
nucleus accumbens, cortex, and brain stem of rats treated with water 
(W) or oxycodone (O1, O2). Two μg of total proteins were spotted on 
NC membrane and then probed with antibodies against either nitro-
tyrosine (3N left membrane) or actin (right membrane). The 3N signal 
was normalized to the corresponding actin signal in each sample and 
then oxycodone data was normalized to the corresponding water 
data. The graph represents the mean ratio of oxycodone to water 
data obtained in three separate experiments using lysates from differ-
ent drug administration experiments (±SEM). Data was analyzed by 
Student’s t test. NuAcc, nucleus accumbens, p < 0.05; Cortex, p < 0.05; 
Stem, brain stem, p < 0.05. Open bars water samples; gray filled bars 
oxycodone samples
▸
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significant increase in BiP level in both nucleus accum-
bens and cortex lysates of oxycodone-treated animals 
suggesting activation of UPR in these brain areas (Fig. 3a, 
middle panels). Interestingly, no changes in the BiP levels 
in brain stem lysates were observed by western blot.
Western blot analysis of brain lysates also demon-
strated a significant increase in the phosphorylated trans-
lation initiation factor 2α (eIF2α) level in all three tissue 
lysates from the oxycodone-exposed animals: nucleus 
accumbens, cortex, and brain stem (Fig. 3a, lower panels). 
The phosphorylation status of eIF2α serves as a marker of 
integrated stress response (ISR) that also includes UPR. 
Since we cannot exclude that, beside endoplasmic retic-
ulum stress, other triggers may contributes to cellular 
stress response leading to phosphorylation of eIF2α, we 
suggest that chronic oxycodone treatment induces inte-
grated stress response in rat brain.
Modulation of the translational machinery is a part 
of the ISR that facilitates cellular adaptation to stress. 
To investigate the effect that oxycodone has on general 
translation, we performed ultracentrifugation of lysates 
from nucleus accumbens in sucrose density gradients. 
We chose lysate from nucleus accumbens because of 
the smaller size of the tissue and higher cellular homo-
geneity compared to other brain tissues containing cor-
tex or brain stem. The polysomal profiles of the nucleus 
accumbens lysates from water and oxycodone-treated 
animals did not show significant differences (Fig.  3b, 
upper panels). Also, the distribution of the large riboso-
mal subunit (60S) along sucrose density gradients was 
similar between oxycodone- and water-exposed nucleus 
accumbens (Fig.  3b, western blot panel, Rs-L7a). How-
ever, distribution of the translation initiation factors 4A 
(eIF4A) and 4E (eIF4E) significantly changed after oxyco-
done exposure (Fig.  3b, western blot panels, eIF4A and 
eIF4E). Although, the majority of the translation initia-
tion factors co-sedimented with ribosomal fractions in 
both water- and oxycodone-exposed tissue lysates (frac-
tions 3 and up), in oxycodone lysate a significant portion 
of eIF4A and eIF4E also accumulated on the top of the 
sucrose density gradients (in fraction 2, which contains 
free proteins complexes and untranslated mRNAs). Inter-
estingly, in oxycodone-treated samples, hsp70 co-sed-
imented with ribosomal complexes (fractions 3 and up) 
and also accumulated on the top of the gradient (frac-
tion 2), similar to eIF4A and eIF4E (Fig. 3b, western blot 
panel, hsp70). Co-sedimentation of hsp70 with ribosomal 
complexes and translation factors is in agreement with 
hsp70’s role in co-translational folding of newly synthe-
sized proteins. Sedimentation of hsp70 at the top of the 
gradient for the oxycodone lysate may indicate accumula-
tion of protein complexes targeted by hsp70 for refolding 
or proteolysis.
Oxycodone stimulates translation of the 
phospho‑eIF2α‑dependent mRNAs
To investigate the effect that chronic oxycodone treat-
ment has on translation of the mRNAs that are spe-
cifically regulated by phosphorylation of eIF2α, we 
monitored the distribution of ATF4 and PDGFRα 
mRNAs in the sucrose density gradients similar to that 
shown on Fig.  3b. The ATF4 mRNA has two upstream 
open reading frames and is known to be translationally 
activated by phosphorylation of eIF2α [32]. The PDGFRα 
mRNA was shown to be translationally de-repressed in a 
PERK-dependent manner following ER stress in mouse 
liver [33]. As a control, we monitored polysomal distribu-
tion of actin mRNA, which synthesizes a house-keeping 
protein and is not translationally regulated by activation 
of the eIF2α kinases [33]. First, we confirmed that oxyco-
done treatment did not affect the total amount of actin, 
ATF4, and PDGFRα mRNAs in the nucleus accumbens 
lysates (data not shown). To investigate the effect that 
oxycodone has on the translational efficiency of actin, 
ATF4 and PDGFRα mRNAs we isolated RNA from each 
fraction of the sucrose density gradients and performed 
real-time PCR assay using specific primers. In Fig.  4a, 
the amount of individual mRNA in each fraction is pre-
sented as a percentage of the amount of this mRNA in all 
12 fractions. To analyze the amount of individual mRNA 
in the polysomal fractions, representing efficiently trans-
lated mRNA (Ps, fractions 7–12), we expressed it as a 
percentage of mRNA sedimented in all fractions set as 
100 % (Fig. 4a, bars below).
We did not observe any changes in actin mRNA dis-
tribution along the sucrose density gradient upon oxy-
codone treatment (Fig. 4a, left panel). Statistical analysis 
showed that about 80  % of the actin mRNA co-sedi-
mented with polyribosomal complexes (fractions 7–12) 
in both water and oxycodone nucleus accumbens sam-
ples. In contrast, a significant portion of ATF4 mRNA 
in water-exposed nucleus accumbens lysate sedimented 
on the top of the sucrose gradients (Fig.  4a, middle 
panel, fractions 3–5), containing inhibited or slowly-
translated mRNAs. However, in oxycodone-exposed 
nucleus accumbens lysate, ATF4 mRNA accumulated 
in the heavier part of the gradient, which contains more 
efficiently translated mRNAs compared to that of the 
water-treated samples (fractions 6–12). Interestingly, 
oxycodone exposure shifted a fraction of the ATF4 
mRNA from the heavy complexes (water sample, frac-
tions 9–12) to the middle part of the gradient, suggest-
ing changes in the rate of translation for this mRNA. 
Statistical analysis showed an increase in the amount 
of ATF4 mRNA that co-sedimented with the polyribo-
somal complexes (fractions 7–12) in oxycodone nucleus 
accumbens lysates (50 ± 1.8 %) compared to that of the 
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Fig. 3 Oxycodone induces integrative stress response in rat brain. a. Western blot analysis of hsp70, BiP and phosphorylated eIF2α in rat brain 
lysates from nucleus accumbens, cortex, and brain stem of rats treated with water (W) or oxycodone (O1, O2). Left, the representative images of 
western blots. Right, graphs of the densitometric analysis of western blots. The graphs represent the mean ratio of signal of hsp70 to GAPDH, BiP to 
actin, or phospho-eIF2α to total eIF2α with oxycodone data normalized to water samples in corresponding tissues (±SEM). Western blot analysis 
was performed for each set of proteins using lysates from three separate drug administration experiments and repeated at least twice for each set 
of lysates. Hsp70, NuAcc, p < 0.001; Cortex, p < 0.001; Stem, p < 0.01. BiP, NuAcc, p < 0.01; Cortex, p < 0.05; Stem, p = 0.38. Phospho-eIF2α, NuAcc, 
p < 0.01; Cortex, p < 0.01; Stem, p < 0.01. Open bars water samples; gray filled bars oxycodone samples. b Polysomal analyses of nucleus accum-
bens in sucrose density gradients. Upper panels the representative images of polysomal distribution of nucleus accumbens lysates from water and 
oxycodone-treated animals in sucrose density gradients. Top of the gradient is on left side of each image. Direction of sedimentation is shown. The 
polysomal analysis was repeated three times using lysates from different drug administration experiments. Lower panels the representative images 
of western blots of 60S ribosomal protein L7a (Rs-L7a), eIF4A, eIF4E, and hsp70 in corresponding fractions (Frs) along sucrose gradients. The western 
blot analysis of proteins was investigated in two sucrose density gradients using lysates from separate drug administration experiments
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water-treated lysates (37  ±  4.3  %). The distribution of 
PDGFRα mRNA along sucrose density gradients also 
changed dramatically after oxycodone exposure. Real-
time PCR analyses showed that in the nucleus accum-
bens of the water-treated animals, the majority of mRNA 
accumulated in fractions 2–6 containing inhibited or 
slowly-translated mRNAs (Fig.  4a, right panel). How-
ever, in the oxycodone-exposed nucleus accumbens, the 
majority of PDGFRα mRNA accumulated in the heavy 
polyribosomal complexes (fractions 9–12), containing 
efficiently translated mRNAs. Statistical analysis showed 
an increase in the amount of PDGFRα mRNA that co-
sedimented with the polyribosomal complexes (frac-
tions 7–12) in oxycodone-treated nucleus accumbens 
lysate (80  ±  0.5  %) compared to that of water-treated 
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Fig. 4 Chronic oxycodone exposure modulates translation in rat nucleus accumbens area. a Upper panels Real-time-PCR analysis of actin, ATF4, and 
PDGFRα mRNAs distribution in sucrose density gradients. Nucleus accumbens lysates were ultracentrifuged and fractionated similar to that shown 
on Fig. 3b. Filled triangle, water; Filled circle, oxycodone samples. Graphs represent percentage of individual mRNA in each fraction. Lower panel 
graphs representing percentage of individual mRNA in polysomal complexes (fractions #7–12) relative to the amount of this mRNA in all twelve frac-
tions. The graphs represent the mean value from three independent polysomal ultracentrifugations (±SEM). Actin, p = 0.95; ATF4, p < 0.05; PDGFRα, 
p < 0.001. Open bars water samples; gray filled bars oxycodone samples. b Immunohistochemical analysis of actin, ATF4, PDGFRα, and phosphoryl-
ated eIF2α staining in nucleus accumbens areas. Left representative images. Scale bar denotes 20 μm. Right statistical analysis of the data. Open bars 
water samples; gray filled bars oxycodone samples. The intensity of actin stating was analyzed using “Density” method, and the intensity of ATF4, 
PDGFRα, and phospho-eIF2α staining was analyzed using MeanQ method. The graphs represent the mean value of intensities measured in brain 
slides obtained from three animals for each treatment (±SEM). In each slide, at least 3 fields containing 13–74 cells each were investigated. Statisti-
cal analysis was performed using Student’s t test. Actin, p = 0.93; ATF4, p < 0.001; PDGFRα, p < 0.001; P-eIF2α, p < 0.01
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oxycodone exposure stimulated translation of ATF4 and 
PDGFRα mRNAs in the rat brain areas containing the 
nucleus accumbens.
To confirm translational activation of ATF4 and 
PDGFRα mRNAs by chronic oxycodone treatment 
we monitored the ATF4 and PDGFRα protein expres-
sion in nucleus accumbens and compared it to the 
actin level. Immunohistochemical staining showed no 
change in actin protein levels after oxycodone treatment 
(Fig. 4b). In contrast, the ATF4 and PDGFRα protein lev-
els increased almost twofold in the nucleus accumbens 
area in animals treated with oxycodone. Interestingly, 
this brain area also demonstrated increased staining for 
phospho-eIF2α (Fig.  4b) and oxidized DNA (Fig.  2a), 
confirming the induction of integrated stress response in 
oxycodone-exposed nucleus accumbens.
Oxycodone differentially activates the ISR in various brain 
areas
To investigate whether chronic oxycodone induces the 
ISR biomarkers in other brain areas we monitored the 
BiP, ATF4, and PDGFRα expression in corpus collosum, 
striatum, cerebral cortex, hippocampus, and cerebel-
lum. In corpus collosum, immunohistochemical analy-
sis revealed that chronic oxycodone administration 
increased percentage of cells expressing BiP, ATF4, and 
PDGFRα by 1.7-, 1.5-, and 1.4-fold respectively (Fig. 5a). 







































Fig. 5 Oxycodone increases ATF4 and PDGFRα expression in corpus collosum and striatum. a Immunohistochemical analysis of BiP, ATF4, and 
PDGFRα in corpus collosum. Upper panels representative images of corpus collosum areas of rats treated with water (W) or oxycodone (O). Scale 
bar denotes 50 μm. Lower bars statistical analysis of the data. Open bars water samples; gray filled bars oxycodone samples. The graphs represent 
the mean value of percentage of cells expressing BiP, ATF4, or PDGFRα in corpus collosum areas obtained from three animals (±SEM). In each slide, 
at least 5 fields containing 25–70 cells were investigated. Statistical analysis was performed using Student’s t test. BiP, p < 0.001; ATF4, p < 0.001, 
PDGFRα, p < 0.001. b Immunohistochemical analysis of ATF4, PDGFRα, and oxidized DNA (8H) in striatum areas of rats treated with water (W) or 
oxycodone (O). Scale bar denotes 20 μm. Arrows point to the blood vessels
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stress as monitored by 8-Hydroxyguanosine signal (data 
not shown). Interestingly, in water animals, 30–50  % of 
cells in corpus collosum showed expression of BiP, ATF4, 
and PDGFRα (Fig.  5a, white bars) suggesting activation 
of the integrated stress response in cells in white matter 
area even under normal conditions. This could be a result 
of endoplasmic reticulum stress due to neuronal activity. 
Induction of oxidative stress by chronic oxycodone treat-
ment may further increase stress level in these cells and, 
thus, stimulate expression of the stress-response proteins 
such as BiP and ATF4. In striatum, the level of ATF4 and 
PDGFRα expression also increased after chronic oxyco-
done exposure (Fig.  5b). Cells lining the blood vessels 
(arrow) showed increased staining for both proteins, 
ATF4 and PDGFRα, as well as oxidized DNA (8H), sug-
gesting induction of the ISR in these cells in response 
to oxidative stress following oxycodone treatment. This 
result also indicates that the ISR may affect the blood–
brain barrier cellular composition during oxycodone 
administration.
In cortical areas, immunohistochemical analysis 
showed almost twofold increase in expression of BiP, 
mostly in pyramidal cells, but no difference in ATF4 and 
PDGFRα staining after oxycodone treatment (Fig.  6a). 
Similarly, oxycodone increased the percentage of cells 
expressing BiP in hippocampal areas, but did not affect 
ATF4 and PDGFRα expression levels (Fig. 6b). These data 
suggest that in specific brain areas, such as cerebral cor-
tex and hippocampus, prolong oxycodone administration 
induces endoplasmic reticulum stress without activation 
of the integrated stress response.
In the cerebellum of oxycodone treated animals, the 
ISR biomarkers: hsp70, BiP, phosphorylated eIF2α, and 
ATF4, were all localized in Purkinje cells, suggesting acti-
vation of endoplasmic reticulum stress and induction of 
the ISR by chronic oxycodone (Fig. 7a). In contrast, the 
majority of the PDGFRα staining increased in granular 
and molecular layers of oxycodone-exposed tissues, simi-
lar to that of oxidized DNA staining (Fig. 7b). This result 
suggests that PDGFRα expression may also be triggered 
by a mechanism other than the ISR during oxycodone 
exposure. 
Oxycodone activates the ISR in MCF‑7 cells
To investigate whether oxycodone induces the integrative 
stress response in an opioid receptor-dependent manner, 
we used breast adenocarcinoma MCF7 cells, which are 
known to express the μ-opioid receptor. First, we pre-
treated cells with either water or 10 μM the opioid recep-
tor antagonist naloxone for 15 min and then added 5 μM 
oxycodone or vehicle and incubated the cells for another 
24 h. We did not observe morphological changes in cells 
treated with oxycodone alone or in combination with 
naloxone (data not shown).
Western blot analyses revealed a significant increase in 
phopsho-eIF2α, ATF4, BiP, and hsp70 staining after incu-
bation with oxycodone, suggesting the induction of endo-
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Fig. 6 Oxycodone increases BiP but not ATF4 and PDGFRα expression in cerebral cortex and hippocampus. a Immunohistochemical analysis of BiP, 
ATF4, and PDGFRα in cerebral cortex of rats treated with water (W) or oxycodone (O). Scale bar denotes 50 μm. b Immunohistochemical analysis of 
BiP, ATF4, and PDGFRα in hippocampus of rats treated with water (W) or oxycodone (O). Scale bar denotes 50 μm
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lane 3 vs 1, “Oxy” vs “None”). Pre-treatment of cells with 
naloxone completely abrogated the increase in phospho-
rylation of eIF2α by oxycodone, suggesting that prolonged 
oxycodone exposure induces the ISR in the receptor-
dependent manner (eIF2α, lane 4 vs 3, “Oxy  +  Nx” vs 
“Oxy”). The ATF4, BiP, and hsp70 levels in cells pre-
treated with naloxone followed by incubation with oxyco-
done varied significantly from experiment to experiment, 
suggesting that other factors may contribute to the 
stress response in a receptor-independent manner (lane 
4 vs 3, “Oxy +  Nx” vs “Oxy”). Interestingly, BiP protein 
levels also significantly increased in cells incubated with 
naloxone alone suggesting that either treatment, prolong 
agonist (oxycodone) or antagonist (naloxone), induces 
endoplasmic reticulum stress in these cells (BiP, lanes 2 
or 3 vs 1, “Nx” or “Oxy” vs “None”). However, naloxone-
induced endoplasmic reticulum stress was not sufficient 
to activate the ISR since naloxone alone failed to increase 
phosphorylation of eIF2α or overexpression of ATF4 and 
hsp70 (lane 2 vs 1, “Nx” vs “None”). These data suggest 
that prolonged oxycodone treatment induces endoplas-

























































Fig. 7 Oxycodone increases ATF4 in purkinjie cells and PDGFRα expression in granular layer of cerebellum. a Immunohistochemical analysis of 
hsp70, BiP, phosphorylated eIF2α, and ATF4 in Purkinje cells. Upper panels representative images of Purkinje cells (arrow) of rats treated with water 
(W) or oxycodone (O). Scale bar denotes 20 μm. WM white matter; GL granule layer; ML molecular layer. Lower bars statistical analysis of the data. 
Open bars water samples; gray filled bars oxycodone samples. The intensity hsp70, BiP, phosphorylated eIF2α, and ATF4 staining in Purkinje cells was 
analyzed using the Q method. The graphs represent the mean value of intensities measured in brain slides obtained from three animals for each 
treatment (±SEM). In each slide, at least 3 fields containing 6–18 Purkinjie cells each were investigated. Statistical analysis was performed using Stu-
dent’s t test. Hsp70, p < 0.01; BiP, p < 0.01; P-eIF2α, p < 0.001; ATF4, p < 0.001. b Upper panels immunohistochemical analysis of PDGFRα and oxidized 
DNA (8H) in granular layers (GL) of rats treated with water (W) or oxycodone (O). Scale bar denotes 20 μm. ML molecular layer. Lower bars statistical 
analysis of the data. Open bars water samples; gray filled bars oxycodone samples. The intensity of PDGFRα and oxidized DNA staining in granule 
cells was analyzed using Density method. The graphs represent the mean value of intensities measured in brain slides obtained from three animals 
for each treatment (±SEM). In each slide, at least 3 fields were investigated. Data was analyzed by Student’s t test. PDGFRα, p < 0.001; 8H, p < 0.01
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Discussion
To investigate the effect of chronic oxycodone adminis-
tration, we treated female 60  day-old Sprague–Dawley 
rats with 15  mg/kg oxycodone or water by oral gavage 
every 24 h for 30 days. We have previously demonstrated 
that this model is well-tolerated by the rats [34, 35]. Some 
tolerance does develop, but there are no measurable 
physiological indices of dependence and withdrawal with 
the continual dosing regimen. The dosing regimen pro-
vides an opioid level leading to antinociception, which 
makes it a clinically relevant model. If there is stress asso-
ciated with the model, we feel that it would be similar to 
that in a human situation.
In this study, we demonstrated that the integrated 
stress response (ISR) is induced by chronic oxycodone 
administration in rats and cell culture models. The ISR 
is activated by various triggers, allowing cells to adapt 
to changing environments or to initiate programmed 
cell death. Hypoxia, endoplasmic reticulum stress due 
to aberrant Ca2+ flow, or the induction of excitotoxic 
stress, are all associated with opioid abuse. The ISR is 
manifested by overexpression of several factors includ-
ing hsp70. Indeed, previously it was found that mor-
phine induces expression of hsp70 in the rat amygdala 
[36], frontal cortex [5, 37], locus coeruleus [8], as well as 
in cultured hippocampal neurons [38]. Moreover, it was 
demonstrated that morphine increases the hsp70 mRNA 
level in rat brain in the temperature-independent man-
ner [37] supporting the idea of stress as a major trigger 
of the opioid-induced hsp70 expression. In this study, we 
also demonstrate that chronic oxycodone administration 
leads to an increase in both hsp70 mRNA and protein 
levels in brain lysates from the nucleus accumbens, cor-
tex, and brain stem. Moreover, ultracentrifugation of the 
nucleus accumbens lysates from oxycodone-treated ani-
mals in sucrose density gradients shows co-sedimenta-
tion of hsp70 with translational complexes that included 
ribosomes, translation initiation factors eIF4E and eIF4A, 
and mRNAs, in agreement with the hsp70 role in co-
translational protein folding. We also observed sedimen-
tation of hsp70 on the top of the gradient possibly with 
unfolded proteins.
Our observation that chronic oxycodone administra-
tion induced expression of hsp70 in various rat brain 
areas is in contrast to several reports that did not find 
evidence for the induction of hsp70 expression after 
opioid treatment. One study investigating the effect of 
chronic oxycodone treatment on the gene expression 
profile in whole rat brain did not detect changes in the 
expression level of hsp70 [9]. This discrepancy could be 
due to the fact that very often the microarray protocol 
involves enrichment of mRNA fraction via purification 
with oligo(dT) magnetic beads. However, since hsp70 
mRNA lacks the poly(A)-tail, it will be lost during sample 
preparation. In another study using human embryonic 
kidney 293 cells expressing MOR1, a 2-h treatment with 
morphine did not increase Hsp70 mRNA expression [37]. 
In the study presented here, we demonstrate induction 
of hsp70 expression in MCF7 cells after 24-h treatment 
with oxycodone, suggesting that late events such as the 
accumulation of cellular damage trigger hsp70 overex-





































Fig. 8 Oxycodone activates the integrated stress response in MCF7 cells. Western blot analysis of phosphorylated and total eIF2α, ATF4, BiP, hsp70, 
and actin in MCF7 cell lysates treated with water and vehicle (None), 10 μM naloxone and vehicle (Nx), water and 5 μM oxycodone (Oxy) or 
combination of 10 μM naloxone and 5 μM oxycodone (Oxy + Nx). Left the representative images of western blots of corresponding proteins. Right 
graphs of the densitometric analysis of western blots. The graphs represent the mean ratio of signal of phosphorylated to total eIF2α, and ATF4, BiP, 
and hsp70 to actin obtained from three individual experiments using separate cell cultures. “Oxy”, “Nx”, and “Oxy + Nx” data were normalized to 
the “None” value set as one (±SEM). To determine statistical significance, data was analyzed by Student’s t test: Oxy vs None: P-eIF2α, BiP, ATF4, and 
hsp70, p < 0.05. Nx vs None: BiP, p < 0.001. Oxy ± Nx vs Oxy: P-eIF2α, p < 0.05; BiP, ATF4, and hsp70, p > 0.18
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of MCF7 cells with naloxone did not completely abolish 
the increase in hsp70 levels by oxycodone supporting 
the idea that late events may trigger cellular stress in a 
receptor-independent manner. One such event could be 
endoplasmic reticulum (ER) stress. Our and others data 
suggest that excessive or chronic opioid administration 
induces ER stress leading to activation of the unfolded 
protein response (UPR). One study demonstrated that 
chronic morphine treatment induced neuronal patho-
logical changes in rough endoplasmic reticulum in the 
ventral tegmental area [39]. In another study, morphine 
administration caused about twofold increase in BiP 
gene level, a biomarker of UPR, in rat frontal cortex 
[5]. We observed BiP protein overexpression in various 
brain areas after chronic oxycodone exposure, including 
the nucleus accumbens, corpus collosum, cerebral cor-
tex, and brain stem. We also demonstrated induction of 
the BiP in MCF7 cells after 24-h oxycodone treatment. 
Naloxone alone also led to increased BiP protein expres-
sion suggesting that both antagonist and prolonged 
agonist treatments are capable to induce endoplasmic 
reticulum stress.
In neurons, activation of BiP by calcium mobilization 
or accumulation of unfolded/damaged proteins in ER 
may lead to phosphorylation of the PKR-like endoplas-
mic reticulum kinase (PERK) and its downstream target, 
translation initiation factor eIF2α, and these initiate the 
UPR. In addition, phosphorylation of eIF2α is also trig-
gered by a variety of other stresses including hypoxia, 
excessive production of ROS and NO or increase in 
extracellular glutamate that activates defensive mecha-
nism called integrated stress response (ISR) [24]. In gen-
eral, phosphorylation of eIF2α leads to the attenuation 
of global protein synthesis but stimulation of translation 
of specific mRNAs containing upstream open-reading 
frames (uORF) in their 5′UTR via leaky scanning [26]. 
Such an approach allows cells to reduce the load of mis-
folded proteins in ER but stimulates expression of pro-
teins necessary for survival during stress. The ATF4 
mRNA has two uORFs and was shown to be translation-
ally up-regulated by phosphorylation of eIF2α [32]. The 
ATF4 is transcription factor that regulates down-stream 
genes expression in response to variety of stresses.
The effect of opioid exposure on activation of inte-
grated stress response including phosphorylation of 
eIF2α and overexpression of ATF4 has never been inves-
tigated. We demonstrated increased phosphorylation 
of eIF2α and translational up-regulation of the ATF4 
mRNA in various areas of rat brain after chronic oxyco-
done treatment including the nucleus accumbens, cor-
pus collosum, striatum, and brain stem. Interestingly, in 
Purkinje cells, hsp70, BiP, phosphor-eIF2α, and ATF4, 
were all localized in cell bodies suggesting induction of 
ER stress and activation of the ISR by chronic oxyco-
done exposure. We also demonstrated overexpression of 
hsp70, BiP, and ATF4 and also increased phosphorylation 
of eIF2α in MCF7 cells after 24-h incubation with oxyco-
done suggesting the direct link between opioid exposure 
and induction of the ISR. Interestingly, phosphorylation 
of eIF2α was abrogated by pretreatment of cells with 
naloxone suggesting the μ-opioid receptor-dependent 
mechanism of the oxycodone-mediated eIF2α phospho-
rylation. However, the rest of ISR members: hsp70, BiP, 
and ATF4 demonstrated fluctuation in response to oxy-
codone after pre-treatment of cells with naloxone, sug-
gesting that part of the stress response in these cells is 
receptor- and phospho-eIF2α-independent.
We also demonstrated translational upregulation of 
PDGFRα mRNA and increased PDGFRα protein expres-
sion in several oxycodone-exposed brain areas. Previously, 
PDGFRα mRNA was identified as one of the mRNAs 
that shifted into polysomes in the eIF2α kinase, PERK, 
activation-dependent manner [33]. We observed locali-
zation of PDGFRα and the ISR machinery, BiP, phopsho-
eIF2α, and ATF4 in nucleus accumbens, striatum, and 
cerebellum. Some cells adjacent to the blood vessels in 
oxycodone-exposed brains demonstrated increased stain-
ing for ATF4, PDGFRα, and oxidized DNA, suggesting 
induction of the ISR in cells controlling the blood–brain 
barrier (BBB) integrity. Previously it was shown that acti-
vation of PDGFRα may contribute to altered BBB perme-
ability as a compensatory effect to increase oxygen flow 
[40, 41]. Indeed, a connection between opioid exposure 
and BBB impairment has been described in several stud-
ies. For example, human brain microvascular endothelial 
cells (HBMEC) treated with morphine induces produc-
tion of PDGF that lead to disruption of BBB [42]. In a rat 
model, withdrawal after chronic morphine administra-
tion resulted in increased BBB permeability [43] that was 
markedly attenuated by pretreatment with an antioxidant 
H-290/51 [44], suggesting a link to the oxidative stress.
Thus, we observed increase in expression of biomarkers 
of the endoplasmic reticulum stress (BiP) and integrated 
stress response (ATF4) in nucleus accumbens, corpus 
collosum, striatum, and Purkinjie cells in rats treated 
with 15 mg/kg oxycodone for 30 days. However, in cor-
tical and hippocampal areas prolong oxycodone treat-
ment stimulated expression of BiP without activation of 
the ISR suggesting different than endoplasmic reticu-
lum rout of stress induction by oxycodone. Since cells in 
these brain areas expressed BiP at lower level even in the 
water-treated animals, it is possible that this pro-survival 
pathway promotes better adaptation of the neuronal cells 
to more severe stress.
The link between other drugs of abuse and induc-
tion of the ISR in brain has been reported. Large doze 
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of methamphetamine induced endoplasmic reticulum 
stress and expression of hsp70, BiP, ATF4, and other 
stress-response biomarkers in rat striatum after just 
1  day of treatment [45]. Interestingly, co-administration 
of methamphetamine with a putative dopamine receptor 
D1-agonist, SCH23390, completely blocked expression of 
these proteins suggesting a receptor-dependent mecha-
nism of the ISR induction. Increase in ATF4 expression 
was demonstrated in response to amphetamine adminis-
tration in rats [46]. The ATF4 transcriptional activity was 
shown to contribute to the post-synaptic terminal and 
dendritic spine morphology [47] suggesting the mecha-
nism of the opioid-induced modulation of neuronal 
plasticity. Methamphetamine [43, 48] and cocaine, have 
been also shown to induce BBB leakage [49]. Thus, our 
and other’s studies suggest that drugs of abuse may acti-
vate the integrated stress response in specific brain areas. 
The members of the ISR machinery may serve as targets 
for the therapeutic protection against drug-induced neu-
ronal impairment and the BBB disruption.
Active protein synthesis is important for neuronal plas-
ticity [50]. Further study needed to investigate how drug 
abuse modulates translational machinery and whether 
these changes contribute to development of tolerance, 
addiction, or pain perception. Overall, this study suggests 
that prolonged opioid treatment affects translational 
machinery via modulation of activity of the translation 
factors that affects translation of specific mRNA and thus 
may contribute to the changes in neuronal plasticity dur-
ing drug abuse.
Conclusions
Our study found that chronic oxycodone administration 
triggers induction of oxidative and nitrosidative stresses 
in rat brain. We demonstrated activation of the inte-
grated stress response: overexpression of hsp70, BiP, and 
ATF4 and also increased phosphorylation of eIF2α, in 
rat brain and MCF7 cell culture by prolonged oxycodone 
treatment. Moreover, we found that prolonged opioid 
treatment affects translational machinery suggesting the 
mechanism of opioid-induced changes in neuronal plas-
ticity during drug abuse that contribute to development 
of tolerance, addiction, or pain perception. Our report 
documenting increased expression of PDGFRα in brain 
tissues after chronic oxycodone treatment also suggests 




Female 60  day-old Sprague–Dawley rats (180–240  g) 
were purchased from Harlan Indianapolis, IN. They were 
fed chow and water ad libitum and maintained on a 12-h 
light/dark cycle. The animals were housed three to a cage 
and allowed to acclimate for at least 1 week before exper-
iments were conducted. The protocol for animal studies 
was approved by the Louisiana State University Health 
Science Center, Institutional Animal Care and Use Com-
mittee. Rats were assigned to one of two groups (n = 3/
group) administered either oxycodone (Mallinckrodt 
Inc., St. Louis, MO, USA) or its vehicle water. Oxycodone 
(15 mg/kg) Fisher’s PLSD or water was administered by 
oral gavage (volume of 1.0 ml/kg) every 24 h for 30 days. 
The oxycodone-treated group was compared directly to 
the water-treated control group, which was handled, 
treated, and sacrificed at the same time and under the 
same conditions. For statistical analysis this treatment 
[three water- (W) and six oxycodone-treated (O1 and 
O2) animals] was repeated three times. To determine the 
toxicity of the oxycodone, rats were weighed daily. There 
was no significant weight loss in either group of animals. 
In addition, anti-nociceptive effect of 15 mg/kg of oxyco-
done treatment was assessed by recording the latency to 
lick the hindpaws when the rat was placed on a hotplate 
(52 °C; maximal latency 30 s) over 30 days of treatment.
Lysates preparation
For Western blot and dot-blot analyses, rats in both 
groups were sacrificed by CO2 asphyxiation and decapi-
tated 2  h after administration of the last dose of oxy-
codone or the water vehicle. Whole-brain tissues were 
harvested, and then tissues containing cortex, nucleus 
accumbens and brain stem were collected in separate 
tubes containing ice-cold buffer A (50  mM Tris–HCl, 
140 mM NaCl, 5 mM KCl, 6 mM MgCl2, and 1 mM Na-
vanadate pH 8.0). The corresponding tissues from three 
rats were pooled together in order to obtain enough 
material for all analyses. Thus, each sample contained 
tissues from three animals. Tissues were homogenized 
in ice-cold buffer B [100  mM Tris–HCl, 150  mM KCl, 
10  mM MgCl2, 200  mM Sucrose, 5  mM DTT, 0.5  mg/
ml heparin, 0.5 % Triton X-100, 0.5 % NP-40, and 0.5 % 
deoxyholate, Complete™ EDTA-free protease inhibi-
tor cocktail (Roche), and phosphatase inhibitor cock-
tails 2 and 3 (Sigma)], by 30 strokes with a Teflon/glass 
homogenizer, incubated on ice for 10  min, pipetted 10 
times with 1 ml tip and centrifuged at 10,000×g at 4 °C 
for 5  min. The supernatants were collected and con-
centration of proteins in the supernatant was measured 
with Micro BCA Protein Assay Kit (Thermo Scientific 
Pierce). Brain tissue lysates (cortex, nucleus accumbens, 
and brain stem) were stored at −80 °C until further pro-
cessing. We choose to investigate these three brain areas 
based on their functions that may contribute to pain 
perception and also cognitive and motor impairment 
(cortex); to reward and the abuse potential (nucleus 
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accumbens); and to mediation of respiratory depression 
and some of the ant-nociceptive and pro-emetic effects 
(brain stem).
Western blot analysis of brain lysates
To analyse the expression of proteins in brain tissues, equal 
amounts of total protein were loaded on a 12 % or 4–12 % 
NuPAGE® Novex® Bis–Tris Gel (Invitrogen). The Full-
Range Rainbow protein molecular weight marker (GE 
Healthcare Life Science) was loaded on the same gel to iden-
tify the position of specific proteins. Proteins were separated 
by SDS-PAGE gel and then transferred to a Nitrocellulose 
membrane (Bio-Rad) using a Mini Trans-Blot cell (Bio-Rad). 
Expression of specific proteins were determined by probing 
the membrane with antibodies against P-CaMKII (Thr286) 
(dilution 1:1000), CaMKII (pan) (dilution 1:1000), P-Erk1/2 
(Thr202/Tyr204) (dilution 1:4000), Erk1/2 (137F5) (dilution 
1:8000), P-PKA Cα (Thr197) (dilution 1:2000), and PKA Cα 
(4782) (dilution 1:8000), P-eIF2α (Ser51) (dilution 1:2000), 
eIF2α (D7D3) XP (dilution 1:4000), HSP70 (D69) (dilution 
1:1000) all from Cell Signalling; cFos (dilution 1:4000) from 
Santa Cruz; GRP78 (BiP) (dilution 1:8000) from Abcam; 
actin (dilution 1:8000) from Sigma; and GAPDH (dilution 
1:8000) from Fitzgerald. Mouse monoclonal anti-eIF4A 
antibody (dilution 1:2000) was a gift from Dr. Hans Trach-
sel, Bern, Switzerland. Rabbit anti-eIF4E antibody (dilution 
1:1000) was a gift from Dr. Robert E. Rhoads, LSUHSC. The 
membranes were incubated with primary antibodies in 5 % 
BSA in buffer TBS-T (20  mM Tris–HCl, 150  mM NaCl, 
and 0.1  % Tween 20, pH 7.5) overnight at 4  °C, washed 
three times for 15 min with TBS-T, and incubated for 1 h 
at room temperature with anti-mouse secondary antibodies 
(for GAPDH and eIF4A antibodies) or anti-rabbit second-
ary antibodies (for all other primary antibodies) conjugated 
with horse-peroxidase (Vector Laboratories, Inc.) in 5  % 
non-fat dry milk in TBS-T. Blots were developed with the 
Western Lightning ECL Pro development kit (PerkinElmer) 
and exposed to HyBlot CL autoradiography film (Denville 
Scientific). Quantitative analysis of Western blot images was 
performed using the ImageQuant TL software (GE Health-
care Life Science). Each sample contained the correspond-
ing brain tissue from three rats. The oxycodone data (O1 or 
O2) were normalized to the corresponding water-control 
data (W) from the same treatment experiment. Results 
are presented as the mean of three independent treatment 
(drug administration) experiments ± SEM. Student’s t test 
was applied to the data to determine statistical significance, 
and data with p value lower than 0.05 was considered to be 
statistically different.
Dot‑blot and statistics analysis
Two micrograms of total lysates from nucleus accum-
bens, cortex, and brain stem of animals treated with 
water or oxycodone were spotted on Nitrocellulose 
membrane. After samples dried, membranes were 
blocked and probed with primary and secondary anti-
bodies as described for western blot analysis. The level of 
nitro-tyrosine in samples was determined using mouse 
antibodies against 3-nitrotyrosine (39B6) (diluted 1:5000) 
from ENZO and anti-mouse secondary antibodies conju-
gated with horse-peroxidase (Vector Laboratories, Inc.) 
in 5  % non-fat dry milk in TBS-T. 3-nitrotyrosine sig-
nals were detected using the Western Lightning ECL Pro 
development kit (PerkinElmer). The same membranes 
were stripped, blocked and then incubated with rabbit 
anti-actin antibodies (dilution 1:5000) from Sigma and 
then with anti-rabbit alkaline-phosphatase conjugated 
secondary antibodies (Vector Laboratories, Inc.). Actin 
signal was visualized using BCIP/NBT color develop-
ment substrate (Promega, Madison, WI, USA). Quantita-
tive analysis of dot-blot images was performed using the 
ImageQuant TL software (GE Healthcare Life Science). 
Each membrane contained one water and two oxycodone 
samples from the same drug administration experiment. 
This experiment was repeated three times using lysates 
from different drug administration experiments. The 3N 
signal was normalized to the corresponding actin signal 
in each sample and then oxycodone data was normal-
ized to the corresponding water data, such as (3Noxy/ 
Actinoxy)/(3Nwater/Actinwater). The graph represents 
the mean ratio of oxycodone to water data (±SEM). To 
determine statistical significance, data was analyzed by 
Student’s t test, and data with p value lower than 0.05 was 
considered to be statistically different.
Immunohistochemical analysis
For immunohistochemical analyses, three rats treated 
with water and three rats treated with oxycodone were 
anesthetized with injection of 65  mg/kg i.p. of sodium 
pentobarbital and then perfused through the aortic 
arch with 100  ml ice-cold saline followed by 400  ml 
ice cold 4  % paraformaldehyde in 0.1  M sodium phos-
phate buffer, pH 7.4 (PB). The whole brain was removed 
and placed in 4 % paraformaldehyde in PB overnight at 
4 °C, transferred to a 15 % sucrose in 0.1 M PB for 24 h, 
then to 30 % sucrose in PB for 24 h and then stored in 
70 % ethanol at 4 °C until further processing. Rat brain 
sections containing cortex and nucleus accumbens 
(plates 12-30, Rat Brain Atlas, Paxinos and Watson) or 
brain stem (plates 122 and later, Rat Brain Atlas, Paxi-
nos and Watson) were embedded in paraffin according 
to a standard protocol, cut into 10 μm thick slices and 
then mounted on glass slides, two or three consecu-
tive slices on one slide (Millennia 1000). Tissue sections 
were deparaffinized by warming in the oven at 65 °C for 
1 h, rehydrated in xylene, 100 % and 95 % solutions of 
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ethanol and then in water. The antigens were retrieved 
by incubation of slides in sub-boiling 10  mM sodium 
citrate, pH 6.0 for 30 min. To reduce non-specific back-
ground sections were incubated with 3  % hydrogen 
peroxide for 10  min at room temperature. Then each 
slide containing two or three sections of rat brain was 
incubated with two different dilutions of primary anti-
bodies and no primary antibodies as a negative con-
trol. Primary antibodies against: 8-Hydroxyguanosine 
(15A3) (dilution 1:400), BiP (GRP78) (dilution 1: 1000), 
and HSP70 (5A5) (dilution 1:50 for cortex and nucleus 
accumbens, and 1:100 for brain stem) from Abcam, and 
actin (dilution 1: 100), ATF4 (dilution 1: 100), P-eIF2α 
(dilution 1: 100), and PDGFRα (dilution 1: 100) were 
diluted in SignalStain Antibody diluent (Cell Signal-
ing). Sections were processed with either VectaStain 
ABC (to detect BiP) or ImmPRESS Anti-Mouse Ig 
Rat adsorbed (peroxidase) Polymer Detection Kits (to 
detect 8-Hydroxyguanosine and HSP70) (Vector Labo-
ratories, Inc.). The signal was visualized by DAB-nickel 
kit (Vector Laboratories, Inc.). The nuclei were stained 
using the hematoxylin Gill’s 3 formulation (VWR) fol-
lowed by wash in 0.2  % ammonia water. Of note, that 
the slides stained with antibodies against 8-Hydroxy-
guanosine were not counterstained with hematoxylin. 
The slides were then treated with graded alcohols and 
xylene. The coverslips were placed using HistoChoice® 
Mounting Media (VWR). Images were taken using 
Olimpus BX43F microscope. To analyse the images we 
used two type of scoring: quick score (Q) and density 
score. The Q method: immunoreactivity was analyzed 
visually by calculating the percentage (P) of cells show-
ing estimated intensity (I) of staining (1, weak; 2, mod-
erate; and 3, strong staining). Results are represented as 
a quick score Q =  P ×  I; maximum 300, as described 
in http://www.ihcworld.com/ihc_scoring.htm. Den-
sity method: immunoreactivity signal was measured 
by ImageQuant TL software (GE Healthcare Life Sci-
ence) and then “value” of the signal was divided to the 
“area” of the image. In both cases results are presented 
as mean of at least three independent experiments using 
brains slides from different animal (±SEM). To deter-
mine statistical significance, data was analyzed by Stu-
dent’s t test, and data with p value lower than 0.05 was 
considered to be statistically different.
Polysomal ultracentrifugation in sucrose density gradients
The nucleus accumbens lysates from the same drug treat-
ment experiment (W and O1 or O2) were analyzed in 
each polysomal ultracentrifugation experiment. An equal 
volume of nucleus accumbens lysate (generally 300  μl) 
was layered onto a 15–45 % (w/v) sucrose gradient con-
taining 100 μg/ml cycloheximide (VWR) and centrifuged 
in a Beckman SW41Ti rotor at 38,000 rpm at 4 °C for 2 h. 
Gradients were collected in 1-ml fractions with continu-
ous monitoring of absorbance at 254  nm using an Isco 
syringe pump with UV-6 detector (Teledyne Isco Inc.). 
Samples were stored at −80  °C until further use. The 
polysomal analysis was repeated three times using lysates 
from different drug administration experiments.
Real‑time PCR of total and polysomal RNA
Before RNA isolation, 600 μl aliquots from each fraction 
after polysomal ultracentrifugation in sucrose density 
gradients were spiked with 100 pg of GFP mRNA (inter-
nal control). Then, RNA was purified with TRIzol®-LS 
reagent (Invitrogen) according to the manufacturer’s 
protocol. The RNA was further precipitated with 0.8  M 
Na-acetate and 1.2  M NaCl, re-suspended in RNase-
free water and precipitated again with 2  M LiCl over-
night at −20  °C. Reverse transcription was performed 
with random primers and reverse transcriptase from the 
TaqMan® Reverse Transcription Reagents kit (Applied 
Biosystems) following the manufacturer’s protocol. 
Quantitative real-time PCR was used to measure the 
GFP, actin, ATF4 and PDGFRα mRNAs level in each frac-
tion. Amplification and detection were performed using 
the iCycler IQ Real-time PCR detection system with IQ™ 
SYBRgreen Supermix (Bio-Rad). The actin, ATF4 and 
PDGFRα mRNA levels were normalized with the GFP 
internal control. Relative amount of individual mRNA 
in each fraction (after normalization to GFP signal) was 
expressed as a percentage of the sum of this mRNA in all 
12 fractions set as 100 %. To assist statistical significance 
of the changes in the mRNA redistribution along the 
sucrose density gradients, the percentage of individual 
mRNA co-sedimented with heavy polyribosomes, con-
taining efficiently translated mRNAs (fractions #7–12), 
was calculated as a percentage of the total mRNA. The 
percentage of individual mRNA in polysomal fractions 
was investigated in three polysomal analyses using lysates 
from three drug administration experiments. Results are 
presented as mean values (±SEM). To determine statisti-
cal significance, data was analyzed by Student’s t test, and 
data with p value lower than 0.05 was considered to be 
statistically different.
Protein analysis in sucrose gradient fractions
Four hundred μl aliquots from each fraction after polyso-
mal ultracentrifugation in sucrose density gradients was 
combined with 44 μl 100  % Trichloroacetic acid (TCA) 
and incubated overnight at 4  °C. After centrifugation at 
15,000×g for 15 min, pellets were washed twice with cold 
acetone (−20 °C), dried under vacuum and re-suspended 
in 100  μl of NuPAGE®LDS sample Buffer (Invitrogen). 
The 20  μl aliquots of fractions 2–11 were loaded on 
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4–12 % NuPAGE® Novex® Bis–Tris Gel, (Invitrogen) and 
analyzed as it described in Western Blot Analysis section. 
The fractions #1 and #12 were excluded from the west-
ern blot analyses due to inability to dissolve the pellet 
after TCA precipitation (fraction #1) and lack of proteins 
(fraction #12) assessed in a separate experiment.
MCF7 cell culture, drug treatment and western blot 
analysis
The MCF7 human breast adenocarcinoma cells (ATCC) 
were maintained in the Dulbecco’s modified Eagle’s 
medium (DMEM)/low glucose (Hyclone, Logan, UT) 
supplemented with 10 % fetal bovine serum and 1 % pen-
icillin–streptomycin (Gibco, Carlsbad, CA). Cells were 
plated into 100 mm plates at 1.6 × 106 cells per plate and 
allowed to adhere overnight. Two hours prior to drug 
treatment, cells were washed with warm PBS and supple-
mented with fresh media. Prior to oxycodone addition, 
cells first were pre-incubated with either water or 10 μM 
of pan opioid-receptor antagonist naloxone hydrochlo-
ride (Sigma) for 15 min. After that 5 μM oxycodone or 
equal volume of vehicle (10  % DMSO in water) were 
added to the plate. Cells were allowed to grow for the next 
24 h and then harvested. To analyze the expression and 
phosphorylation of proteins, cells were lysed directly on 
a plate in cold RIPA–EDTA buffer (50 mmol/L Tris–HCl, 
150 mmol/L NaCl, 1 % NP-40, 0.5 % sodium deoxycho-
late, 0.1 % SDS, and 5 mmol/L EDTA, pH 7.4) contain-
ing phosphatase inhibitor cocktails 2 and 3 (Sigma), and 
protease inhibitor (Pierce). Cells were scraped, col-
lected, and then protein concentration was determined 
using BCA protein assay kit (Pierce, Rockford, IL, USA). 
Ten micrograms of total protein were resolved on the 
4–12  % NuPAGE® Novex® Bis–Tris Gel (Invitrogen) by 
SDS-PAGE, transferred to a Nitrocellulose membrane 
(Bio-Rad) and then analyzed by western blotting as it is 
described for the brain lysate analysis. The hsp70, BiP, 
and ATF4 signals were normalized to the actin in cor-
responding sample. The phosphor-eIF2α signal was nor-
malized to the total eIF2α in corresponding sample. To 
analyze the effect of each treatment on the expression of 
proteins, normalized signals from oxycodone, naloxone, 
and naloxone plus oxycodone samples were compared to 
the corresponding data from the control lysate. To deter-
mine statistical significance of the effect caused by the 
treatment, data from oxycodone or naloxone were com-
pared to the control using Student’s t test, and data with 
p value lower than 0.05 was considered to be statistically 
different. To investigate whether oxycodone induces the 
ISR in the µ-opioid-receptor dependent manner, normal-
ized signals from the cells treated with oxycodone plus 
naloxone were compared to the data from the oxycodone 
treated cells using Student’s t test, and data with p value 
lower than 0.05 was considered to be statistically differ-
ent. Results are presented as mean values (±SEM) of 
three independent experiments using different cell cul-
tures. For each experiment, western blot was repeated at 
least twice.
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